Artiklar med krav på offentlig åtkomst - Martin FassnachtLäs mer
TotaltDFGNIHBMBFEuropean CommissionNIHRSNSFMRCGovernment of SpainCancer Research UKINSERMWellcomeAIRC Foundation for Cancer Research in ItalyBanking Foundation "la Caixa"Government of ItalyAcademy of Medical Sciences, UKVAHelmholtzVetenskapsrådetBBSRCDiabetes UKANRFAPESPDoDGBMFAHACIHRNSFCEMBLDSTTelethonWorldwide Cancer Research, UKSCLNKFICZI
Inte tillgängliga någonstans: 33
Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients
Z Erlic, L Rybicki, M Peczkowska, H Golcher, PH Kann, M Brauckhoff, ...
Clinical Cancer Research 15 (20), 6378-6385, 2009
Krav: German Research Foundation
Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites
M Peitzsch, D Pelzel, S Glöckner, A Prejbisz, M Fassnacht, F Beuschlein, ...
Clinica Chimica Acta 418, 50-58, 2013
Krav: German Research Foundation
Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients
C Drechsler, A Schneider, L Gutjahr-Lengsfeld, M Kroiss, JJ Carrero, ...
American journal of kidney diseases 63 (6), 988-996, 2014
Krav: Vetenskapsrådet
Next-generation therapies for adrenocortical carcinoma
B Altieri, CL Ronchi, M Kroiss, M Fassnacht
Best Practice & Research Clinical Endocrinology & Metabolism 34 (3), 101434, 2020
Krav: German Research Foundation
Measurements of plasma metanephrines by immunoassay vs liquid chromatography with tandem mass spectrometry for diagnosis of pheochromocytoma
D Weismann, M Peitzsch, A Raida, A Prejbisz, M Gosk, A Riester, ...
European Journal of Endocrinology 172 (3), 251-260, 2015
Krav: German Research Foundation
Sino-European differences in the genetic landscape and clinical presentation of pheochromocytoma and paraganglioma
J Jiang, J Zhang, Y Pang, N Bechmann, M Li, M Monteagudo, B Calsina, ...
The Journal of Clinical Endocrinology & Metabolism 105 (10), 3295-3307, 2020
Krav: National Natural Science Foundation of China, German Research Foundation …
HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas
N Bechmann, ML Moskopp, M Ullrich, B Calsina, PW Wallace, S Richter, ...
Endocrine-related cancer 27 (11), 625-640, 2020
Krav: German Research Foundation
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma
DC Smith, M Kroiss, E Kebebew, MA Habra, R Chugh, BJ Schneider, ...
Investigational new drugs 38, 1421-1429, 2020
Krav: US National Institutes of Health
Patterns of lymph node recurrence in adrenocortical carcinoma: possible implications for primary surgical treatment
J Reibetanz, B Rinn, AS Kunz, S Flemming, CL Ronchi, M Kroiss, ...
Annals of surgical oncology 26, 531-538, 2019
Krav: German Research Foundation
Does bariatric surgery change olfactory perception? Results of the early postoperative course
CF Jurowich, F Seyfried, AD Miras, M Bueter, J Deckelmann, M Fassnacht, ...
International journal of colorectal disease 29, 253-260, 2014
Krav: UK Medical Research Council
Endocrine tumours: Our experience with the management of patients with non-metastatic adrenocortical carcinoma
M Terzolo, M Fassnacht
European Journal of Endocrinology 187 (3), R27-R40, 2022
Krav: German Research Foundation, AIRC Foundation for Cancer Research in Italy
Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort study
F Majidi, S Martino, M Kondakci, C Antke, M Haase, V Chortis, W Arlt, ...
European journal of endocrinology 183 (4), 453-462, 2020
Krav: Academy of Medical Sciences, UK, Cancer Research UK, National Institute for …
Current TNM classification systems for adrenocortical carcinoma
M Fassnacht, C Wittekind, B Allolio
Der Pathologe 31, 374-378, 2010
Krav: German Research Foundation
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures
K Wang, I Schütze, S Gulde, N Bechmann, S Richter, J Helm, M Lauseker, ...
Endocrine-Related Cancer 29 (6), 285-306, 2022
Krav: German Research Foundation
Real-world efficacy and safety of multi-tyrosine kinase inhibitors in radioiodine refractory thyroid cancer
VF Koehler, E Berg, P Adam, GL Weber, A Pfestroff, M Luster, JM Kutsch, ...
Thyroid 31 (10), 1531-1541, 2021
Krav: German Research Foundation
The challenges of sodium measurements: indirect versus direct ion-selective method
J Refardt, CO Sailer, I Chifu, B Winzeler, I Schnyder, M Fassnacht, ...
European journal of endocrinology 181 (2), 193-199, 2019
Krav: Swiss National Science Foundation, German Research Foundation, Federal …
Etomidate unmasks intraadrenal regulation of steroidogenesis and proliferation in adrenal cortical cell lines
S Hahner, A Stürmer, M Fassnacht, RW Hartmann, K Schewe, S Cochran, ...
Hormone and Metabolic Research 42 (07), 528-534, 2010
Krav: US National Institutes of Health
Dendritic cell based immunotherapy-a promising therapeutic approach for endocrine malignancies
S Sbiera, S Wortmann, M Fassnacht
Hormone and metabolic research 40 (02), 89-98, 2008
Krav: German Research Foundation
Adrenomedullary function, obesity and permissive influences of catecholamines on body mass in patients with chromaffin cell tumours
Y An, M Reimann, J Masjkur, K Langton, M Peitzsch, T Deutschbein, ...
International Journal of Obesity 43 (2), 263-275, 2019
Krav: German Research Foundation
A method for the minimally invasive drug monitoring of mitotane by means of volumetric absorptive microsampling for a home-based therapeutic drug monitoring
B Friedl, M Kurlbaum, M Kroiss, M Fassnacht, O Scherf-Clavel
Analytical and Bioanalytical Chemistry 411, 3951-3962, 2019
Krav: German Research Foundation
Publikations- och finansieringsuppgifter tas fram automatiskt av ett datorprogram.